Ecovyst Inc. ECVT

Healthcare SIC 2800 - Chemicals & Allied Products NYSE

Ecovyst Inc. ("Ecovyst" or the "Company"), formerly PQ Group Holdings Inc., was incorporated in Delaware on August 7, 2015. We trace our roots to the late 1800s with our first sulfuric acid plant and the beginning of our oldest customer relationship.

Our common stock is listed on the New York Stock Exchange under the stock ticker "ECVT". Unless the context otherwise indicates, the terms "Ecovyst Inc.," "we," "us," "our," or the "Company" mean Ecovyst Inc. and our subsidiaries.

Effective on December 31, 2025, we completed the sale of our Advanced Materials & Catalysts segment, which includes our investment in affiliated companies, Zeolyst International and Zeolyst C.V. (collectively, the "Zeolyst Joint Venture") to Technip Energies N.V. for a purchase price of $556.0 million, subject to certain adjustments set forth in the agreement. We used $465.0 million of the net cash proceeds to partially repay the Senior Secured Term Loan Facility due June 2031. The results of operations, financial condition and cash flows for the Advanced Materials & Catalysts business are presented herein as discontinued operations. Refer to Note 4 to our consolidated financial statements for additional information.

Last close 10.21 2026-09-04
Market cap $1.12B 2026-06-30 share count
52-week range 7.41 - 15.09

Valuation FY2025 figures against the last close

P/S1.5x
P/E
P/FCF16.0x
EV/EBITDA9.9x
Dividend yield
Diluted EPS-0.61

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $723.5M$598.3M$584.8M$820.2M$611.2M$495.9M$532.7M$527.7M$1.47B$1.06B
Cost of revenue $565.4M$434.9M$418.4M$595.5M$434.5M$345.0M$365.5M$369.6M$1.10B$810.1M
Gross profit $158.1M$163.4M$166.4M$224.6M$176.7M$151.0M$167.2M$158.0M$376.8M$254.1M
R&D $6.8M$7.8M$7.2M$7.5M$7.1M$7.4M$8.9M$13.9M$7.3M
SG&A $66.0M$65.4M$60.5M$85.3M$97.8M$81.5M$83.5M$85.0M$146.7M$110.3M
Operating income $64.9M$85.1M$89.6M$104.4M$54.6M$51.6M$66.0M$69.8M$165.9M$81.5M
Interest expense $34.2M$36.5M$31.7M$37.2M$37.0M$50.4M$66.9M$72.3M$179.0M$140.3M
Pre-tax income $25.8M$45.2M$56.9M$94.7M$13.9M$2.2M$43.4M$13.2M-$60.6M-$69.1M
Income tax $19.5M$299.0K$8.7M$24.9M$12.1M$52.1M$12.3M$8.0M$119.2M$10.0M
Net income -$71.1M-$6.7M$71.2M$69.8M$1.8M-$278.8M$79.5M$58.3M$57.6M-$79.7M
EPS, basic -0.62-0.060.600.55-1.03-2.060.590.440.52-1.02
EPS, diluted -0.61-0.060.600.55-1.02-2.040.590.430.52-1.02
Shares, diluted (wtd. avg.) $116.0M$117.4M$119.5M$135.1M$137.7M$136.5M$135.5M$134.7M$111.7M$78.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $197.2M$131.4M$72.7M$110.9M$140.9M$113.4M$36.1M$37.2M$66.2M$85.1M
Receivables $85.3M$53.2M$81.3M$74.8M$80.8M$45.9M$140.0M$196.8M$193.5M$160.6M
Inventory $26.8M$18.0M$45.1M$44.4M$53.8M$52.8M$137.6M$264.7M$262.4M$227.0M
Total current assets $319.4M$303.7M$246.0M$267.7M$291.7M$428.7M$569.5M$558.6M$549.0M$492.7M
Property, plant and equipment $481.2M$458.7M$576.9M$584.9M$596.2M$591.7M$1.01B$1.21B$1.23B$1.18B
Goodwill $326.7M$326.6M$404.5M$403.2M$406.1M$391.6M$390.5M$969.7M$1.31B$1.24B
Other intangibles $59.3M$67.7M$116.5M$129.9M$145.6M$137.4M$555.3M$728.4M$786.1M$816.6M
Total assets $1.26B$1.80B$1.84B$1.88B$1.93B$3.20B$4.32B$4.33B$4.42B$4.26B
Accounts payable $48.0M$32.9M$40.2M$40.0M$51.9M$38.1M$115.0M$148.4M$149.3M$128.5M
Short-term debt $0$8.7M$9.0M$9.0M$9.0M$0$0$7.2M$45.2M$14.5M
Total current liabilities $120.8M$115.1M$119.1M$129.4M$145.1M$201.9M$270.4M$255.6M$288.4M$242.4M
Long-term debt $392.6M$852.1M$858.9M$865.9M$872.8M$1.40B$1.84B$2.11B$2.19B$2.55B
Total liabilities $657.5M$1.10B$1.13B$1.18B$1.19B$1.92B$2.54B$2.66B$2.78B$3.23B
Retained earnings -$248.6M-$177.5M-$170.9M-$242.0M-$315.7M-$175.8M$103.0M$25.5M-$32.8M-$90.4M
Total equity $603.4M$700.5M$705.5M$707.2M$740.7M$1.28B$1.79B$1.66B$1.63B$1.03B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $140.3M$149.9M$137.6M$186.6M$129.9M$223.6M$267.8M$248.6M$165.2M$122.7M
Depreciation and amortisation $67.8M$59.9M$55.3M$79.2M$79.7M$76.9M$74.8M$72.2M$177.1M$128.3M
Stock-based compensation $9.7M$11.1M$13.0M$20.6M$31.8M$17.2M$13.3M$16.9M$8.8M$5.4M
Capital expenditure $70.4M$55.6M$59.0M$58.9M$60.0M$54.8M$55.3M$55.1M$140.5M$121.4M
Investing cash flow $435.4M-$73.5M-$65.3M-$63.0M$835.7M$551.5M-$35.4M-$119.3M-$196.0M-$1.92B
Financing cash flow -$525.0M-$17.8M-$93.5M-$148.2M-$964.2M-$722.8M-$216.1M-$137.2M$19.8M$1.86B
Dividends paid $0$0$435.6M$243.7M$0$0
Buybacks $46.9M$5.0M$78.7M$136.7M$0$2.1M$3.6M$2.9M$2.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001140361-26-014838.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $10.12B 42.8x 3.1%
PRM Perimeter Solutions, Inc. $5.20B 16.4%
NGVT Ingevity Corp $2.43B -2.7%
IOSP INNOSPEC INC. $2.31B 20.1x -3.7%
CC Chemours Co $2.30B 0.4%
OLN OLIN Corp $1.98B 3.7%
HUN Huntsman CORP $1.69B -5.8%
FMC FMC CORP $1.62B -18.3%